Form D · Other Health Care
New Way Labs, LLC
Dallas, TX · CIK 0001622831
Offering snapshot reported Dec 1, 2015 · SEC filing
- Reported sold
- $80K Offering amount: $200K
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $2.5K Reported outside-investor minimum
- First sale
- Nov 1, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 1, 2015 | Amendment | $80,000 | No comparison | 0 | SEC filing |
| Oct 20, 2014 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-226786
Source: Form D, filed Dec 1, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nick Arthur Austin | Executive |
| Josh James Daniel | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
5710 Lbj Freeway Suite 281
Dallas, TX, 75240
Dallas, TX, 75240